Does ITL help everyone with cancer?
A. There are approximately 180 different diseases classified as “cancer”. Many of these respond to immune modulation therapies. Some do not. Further, when disease becomes diffuse, it can overwhelm the immune system and adversely affect therapy outcome. Patients who recently received extensive immuno-suppressive therapies such as chemotherapy and/or radiation therapy will typically demonstrate a slower response to ITL.
